Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 6/2014

01.06.2014 | Cardiac Nuclear Imaging (A Cuocolo, Section Editor)

Prognostic Value of Stress Myocardial Perfusion Imaging in Asymptomatic Diabetic Patients

verfasst von: Wanda Acampa, Valeria Cantoni, Roberta Green, Renato Cuocolo, Maria Piera Petretta, Massimiliano Orlandi, Mario Petretta

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Although there has been a marked decline in mortality due to coronary artery disease (CAD) in the overall population in the past three decades, reducing CAD mortality in patients with diabetes has proven exceptionally difficult. Several epidemiological studies have shown that diabetes is associated with a marked increase in the risk of CAD. The symptoms are not a reliable means of identifying patients at higher risk considering that angina is threefold less common in diabetics than in nondiabetics. The increasing prevalence of diabetes and the associated high cardiac risk raised the question as to the need to develop approaches to identify the diabetic patients at the highest risk of CAD. Stress myocardial perfusion single-photon emission computed tomography has taken a central role in the diagnosis, evaluation, and management of CAD in diabetic patients. This review focuses on the prognostic value of cardiac radionuclide imaging in asymptomatic diabetic patients.
Literatur
1.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.PubMedCrossRef Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.PubMedCrossRef
2.
Zurück zum Zitat Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care. 1999;22:1396–400.PubMedCrossRef Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care. 1999;22:1396–400.PubMedCrossRef
3.
Zurück zum Zitat May O, Arildsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population-based study. Cardiovasc Res. 1997;34:241–7.PubMedCrossRef May O, Arildsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population-based study. Cardiovasc Res. 1997;34:241–7.PubMedCrossRef
4.
Zurück zum Zitat Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.PubMedCrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.PubMedCrossRef
6.
Zurück zum Zitat Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–7.PubMedCrossRef Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–7.PubMedCrossRef
7.
Zurück zum Zitat Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44.PubMedCrossRef Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44.PubMedCrossRef
8.
Zurück zum Zitat Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol. 2002;40:946–53.PubMedCrossRef Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol. 2002;40:946–53.PubMedCrossRef
9.
Zurück zum Zitat Donnan PT, Boyle DI, Broomhall J, et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabet Med. 2002;19:448–55.PubMedCrossRef Donnan PT, Boyle DI, Broomhall J, et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabet Med. 2002;19:448–55.PubMedCrossRef
10.
Zurück zum Zitat Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266–71.PubMedCrossRef Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266–71.PubMedCrossRef
11.
Zurück zum Zitat Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart. Circulation. 1995;92:2333–42.PubMedCrossRef Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart. Circulation. 1995;92:2333–42.PubMedCrossRef
12.
Zurück zum Zitat Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890–6.PubMedCrossRef Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890–6.PubMedCrossRef
13.
14.
Zurück zum Zitat Grundy SM, Cleeman JI, Merz CN, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–39.PubMedCrossRef Grundy SM, Cleeman JI, Merz CN, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–39.PubMedCrossRef
15.
Zurück zum Zitat Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100–7.PubMedCrossRef Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100–7.PubMedCrossRef
16.
Zurück zum Zitat McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131:443–53.PubMed McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131:443–53.PubMed
17.
Zurück zum Zitat Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.PubMedCrossRef Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.PubMedCrossRef
18.
Zurück zum Zitat Petretta M, Acampa W, Fiumara G, Cuocolo A. Cardiovascular risk stratification in diabetic patients. Clin Transl Imaging. 2013;1:325–39. Petretta M, Acampa W, Fiumara G, Cuocolo A. Cardiovascular risk stratification in diabetic patients. Clin Transl Imaging. 2013;1:325–39.
19.
Zurück zum Zitat Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939–42.PubMedCentralPubMedCrossRef Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939–42.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855–60.PubMedCrossRef Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855–60.PubMedCrossRef
21.
Zurück zum Zitat Acampa W, Petretta M, Evangelista L, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging. 2012;39:387–95.PubMedCrossRef Acampa W, Petretta M, Evangelista L, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging. 2012;39:387–95.PubMedCrossRef
22.
Zurück zum Zitat Bax JJ, Bonow RO, Tschöpe D, Inzucchi SE, Barrett E, Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2006;48:754–60.PubMedCrossRef Bax JJ, Bonow RO, Tschöpe D, Inzucchi SE, Barrett E, Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2006;48:754–60.PubMedCrossRef
23.
Zurück zum Zitat Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol. 2006;48:761–4.PubMedCrossRef Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol. 2006;48:761–4.PubMedCrossRef
24.
Zurück zum Zitat Miller TD, Shaw LJ. Risk stratification in diabetic patients: a continuing challenge. J Nucl Cardiol. 2009;16:486–9.PubMedCrossRef Miller TD, Shaw LJ. Risk stratification in diabetic patients: a continuing challenge. J Nucl Cardiol. 2009;16:486–9.PubMedCrossRef
25.
Zurück zum Zitat Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002;33:1776–81.PubMedCrossRef Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002;33:1776–81.PubMedCrossRef
26.
Zurück zum Zitat Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–9.CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–9.CrossRef
27.
Zurück zum Zitat American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;21:1551–9.CrossRef American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;21:1551–9.CrossRef
28.
Zurück zum Zitat Wackers FJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.PubMedCrossRef Wackers FJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.PubMedCrossRef
29.
Zurück zum Zitat Wackers FJ, Zaret BL. Detection of myocardial ischemia in patients with diabetes mellitus. Circulation. 2002;105:5–7.PubMed Wackers FJ, Zaret BL. Detection of myocardial ischemia in patients with diabetes mellitus. Circulation. 2002;105:5–7.PubMed
30.
Zurück zum Zitat Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:43–9.PubMedCrossRef Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:43–9.PubMedCrossRef
31.
Zurück zum Zitat Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:65–71.PubMedCrossRef Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:65–71.PubMedCrossRef
32.
Zurück zum Zitat Torremocha F, Hadjadj S, Carrié F, Rosenberg T, Herpin D, Maréchaud R. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab. 2001;27:49–57.PubMed Torremocha F, Hadjadj S, Carrié F, Rosenberg T, Herpin D, Maréchaud R. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab. 2001;27:49–57.PubMed
33.
Zurück zum Zitat Le Feuvre CL, Barthélémy O, Dubois-Laforgue D, et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab. 2005;31:135–42.PubMedCrossRef Le Feuvre CL, Barthélémy O, Dubois-Laforgue D, et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab. 2005;31:135–42.PubMedCrossRef
34.
Zurück zum Zitat Senior PA, Welsh RC, McDonald CG, Paty BW, Shapiro AM, Ryan EA. Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care. 2005;28:866–72.PubMedCrossRef Senior PA, Welsh RC, McDonald CG, Paty BW, Shapiro AM, Ryan EA. Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care. 2005;28:866–72.PubMedCrossRef
35.
Zurück zum Zitat Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004;25:543–50.PubMedCrossRef Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004;25:543–50.PubMedCrossRef
36.
Zurück zum Zitat Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with diabetes type 2: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547–55.PubMedCentralPubMedCrossRef Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with diabetes type 2: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547–55.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
38.
Zurück zum Zitat Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304:1350–7.PubMedCrossRef Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304:1350–7.PubMedCrossRef
39.
Zurück zum Zitat Bansal S, Wackers FJ, Inzucchi SE, et al. Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis. Diabetes Care. 2011;34:204–9.PubMedCentralPubMedCrossRef Bansal S, Wackers FJ, Inzucchi SE, et al. Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis. Diabetes Care. 2011;34:204–9.PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 2010;36:91–6.PubMedCrossRef Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 2010;36:91–6.PubMedCrossRef
41.
Zurück zum Zitat Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol. 2010;56:98–105.PubMedCrossRef Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol. 2010;56:98–105.PubMedCrossRef
43.
Zurück zum Zitat Greenland P, Alpert JS, Beller GA, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584–636.PubMedCrossRef Greenland P, Alpert JS, Beller GA, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584–636.PubMedCrossRef
44.
Zurück zum Zitat Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef
45.
Zurück zum Zitat De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–32.PubMedCrossRef De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–32.PubMedCrossRef
46.
Zurück zum Zitat Valensi P, Pariès J, Brulport-Cerisier V, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005;28:2722–7.PubMedCrossRef Valensi P, Pariès J, Brulport-Cerisier V, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005;28:2722–7.PubMedCrossRef
47.
Zurück zum Zitat Faglia E, Favales F, Calia P, Milan Study on Atherosclerosis and Diabetes (MiSAD), et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002;25:2032–6.PubMedCrossRef Faglia E, Favales F, Calia P, Milan Study on Atherosclerosis and Diabetes (MiSAD), et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002;25:2032–6.PubMedCrossRef
48.
Zurück zum Zitat Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging. Circ Cardiovasc Imaging. 2013;6:466–77.PubMedCentralPubMedCrossRef Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging. Circ Cardiovasc Imaging. 2013;6:466–77.PubMedCentralPubMedCrossRef
49.•
Zurück zum Zitat Petretta M, Cuocolo A. Prediction models for risk classification in cardiovascular disease. Eur J Nucl Med Mol Imaging. 2012;39:1959–69. Different prediction models to be used for risk stratification.PubMedCrossRef Petretta M, Cuocolo A. Prediction models for risk classification in cardiovascular disease. Eur J Nucl Med Mol Imaging. 2012;39:1959–69. Different prediction models to be used for risk stratification.PubMedCrossRef
50.
Zurück zum Zitat Petretta M, Acampa W, Evangelista L, et al. (2013) Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2013.11.009 Petretta M, Acampa W, Evangelista L, et al. (2013) Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram. Nutr Metab Cardiovasc Dis. doi:10.​1016/​j.​numecd.​2013.​11.​009
51.
Zurück zum Zitat Acampa W, Petretta M, Daniele S, et al. Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis. 2013;227:307–12.PubMedCrossRef Acampa W, Petretta M, Daniele S, et al. Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis. 2013;227:307–12.PubMedCrossRef
52.
Zurück zum Zitat Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef
53.•
Zurück zum Zitat Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J Nucl Cardiol. 2014;21:50–6. New data regarding the warranty period in diabetic patients.PubMedCrossRef Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J Nucl Cardiol. 2014;21:50–6. New data regarding the warranty period in diabetic patients.PubMedCrossRef
54.
Zurück zum Zitat Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes. Part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol. 2007;49:631–42.PubMedCrossRef Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes. Part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol. 2007;49:631–42.PubMedCrossRef
55.
Zurück zum Zitat Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc. 2002;287:2570–81.CrossRef Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc. 2002;287:2570–81.CrossRef
56.
Zurück zum Zitat Navare SM, Katten D, Johnson LL, et al. Risk stratification with electrocardiographic-gated dobutamine stress technetium-99 m sestamibi single-photon emission tomographic imaging. Value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol. 2006;47:781–8.PubMedCrossRef Navare SM, Katten D, Johnson LL, et al. Risk stratification with electrocardiographic-gated dobutamine stress technetium-99 m sestamibi single-photon emission tomographic imaging. Value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol. 2006;47:781–8.PubMedCrossRef
57.
Zurück zum Zitat Petretta M, Acampa W, Daniele S, et al. Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients. J Nucl Cardiol. 2013;20:45–52.PubMedCrossRef Petretta M, Acampa W, Daniele S, et al. Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients. J Nucl Cardiol. 2013;20:45–52.PubMedCrossRef
58.
Zurück zum Zitat Petretta M, Acampa W, Daniele S, Petretta MP, Plaitano M, Cuocolo A. Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization. Circ Cardiovasc Imaging. 2013;6:908–15.PubMedCrossRef Petretta M, Acampa W, Daniele S, Petretta MP, Plaitano M, Cuocolo A. Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization. Circ Cardiovasc Imaging. 2013;6:908–15.PubMedCrossRef
Metadaten
Titel
Prognostic Value of Stress Myocardial Perfusion Imaging in Asymptomatic Diabetic Patients
verfasst von
Wanda Acampa
Valeria Cantoni
Roberta Green
Renato Cuocolo
Maria Piera Petretta
Massimiliano Orlandi
Mario Petretta
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 6/2014
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-014-9268-y

Weitere Artikel der Ausgabe 6/2014

Current Cardiovascular Imaging Reports 6/2014 Zur Ausgabe

Cardiac Nuclear Imaging (A Cuocolo, Section Editor)

Improving Nuclear Cardiology Practice

Heart Failure and Targeted Imaging (T Schindler and E Schelbert, Section Editors)

Subclinical Myocardial Disease in Heart Failure Detected by CMR

Cardiac Nuclear Imaging (A Cuocolo, Section Editor)

SPECT and PET Protocols for Imaging Myocardial Viability

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.